HI
ACOR

HBK Investments’s Acorda Therapeutics ACOR Stock Holding History

HBK Investments’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-234
Closed -$806K – 1389
2018
Q2 		$806K Buy
+234
New +$717K 0.01% 692
2016
Q3 		– Sell
-239
Closed -$732K – 1059
2016
Q2 		$732K Sell
239
-110
-32% -$358K 0.01% 646
2016
Q1 		$1.11M Buy
+349
New +$1.45M 0.01% 563
2015
Q2 		– Sell
-95
Closed -$380K – 1138
2015
Q1 		$380K Sell
95
-24
-20% -$110K ﹤0.01% 809
2014
Q4 		$584K Buy
+119
New +$511K 0.01% 691
2014
Q1 		– Sell
-400
Closed -$1.4M – 1079
2013
Q4 		$1.4M Buy
+400
New +$1.56M 0.03% 374
2013
Q3 		– Sell
-68
Closed -$267K – 983
2013
Q2 		$267K Buy
+68
New +$280K ﹤0.01% 699

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HBK Investments's ACOR Position: Q3 2018 in Review

HBK Investments sold out of Acorda Therapeutics (ACOR) in Q3 2018, closing a stake of 234 shares — an estimated $806K sold.

HBK Investments first reported a position in ACOR in Q2 2013 and held it in 7 quarters. The position peaked at $1.4M in Q4 2013. 174 funds tracked by Wall St. Rank hold ACOR as of Q3 2018.

  • HBK Investments reported no remaining Acorda Therapeutics position as of Q3 2018 after selling out during the quarter.
  • HBK Investments sold 234 Acorda Therapeutics shares in Q3 2018, an estimated $806K.
  • HBK Investments first reported a position in Acorda Therapeutics in Q2 2013 and held it in 7 quarters.
  • HBK Investments's Acorda Therapeutics position peaked at $1.4M in Q4 2013.
  • 174 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2018.

Based on HBK Investments's 13F filing for Q3 2018, filed 14 Nov 2018.